Strategic Partners A/S (CPH:STRAP)
Denmark · Delayed Price · Currency is DKK 714.00
+44.00 (6.57%)
At close: Jan 22, 2026
Strategic Partners Market Cap
Strategic Partners has a market cap or net worth of 29.78 million as of January 22, 2026. Its market cap has decreased by -28.60% in one year.
Market Cap
29.78M
Enterprise Value
14.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
714.00
Market Cap Chart
Since November 21, 2017, Strategic Partners's market cap has decreased from 1.59B to 29.78M, a decrease of -98.13%. That is a compound annual growth rate of -38.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 29.78M | 2.29% |
| Dec 30, 2025 | 29.11M | -15.40% |
| Dec 30, 2024 | 34.42M | -26.72% |
| Dec 29, 2023 | 46.96M | 51.14% |
| Dec 30, 2022 | 31.07M | -94.82% |
| Dec 30, 2021 | 599.78M | -74.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.68T |
| Genmab | 123.08B |
| Coloplast | 122.33B |
| ALK-Abelló | 48.84B |
| BioPorto | 509.95M |
| Pharma Equity Group | 126.44M |
| ViroGates | 119.74M |
| Scandinavian Medical Solutions | 104.27M |